0001127602-18-012796.txt : 20180326
0001127602-18-012796.hdr.sgml : 20180326
20180326184800
ACCESSION NUMBER: 0001127602-18-012796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180323
FILED AS OF DATE: 20180326
DATE AS OF CHANGE: 20180326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cogan John Francis
CENTRAL INDEX KEY: 0001319872
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 18713784
MAIL ADDRESS:
STREET 1: 2010 NORTH FIRST STREET, SUITE 310
CITY: SAN JOSE
STATE: CA
ZIP: 95131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-03-23
0000882095
GILEAD SCIENCES INC
GILD
0001319872
Cogan John Francis
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
Common Stock
2018-03-23
4
M
0
5833
26.615
A
58452
D
Common Stock
2018-03-23
4
S
0
5833
75.0193
D
52619
D
Non-qualified Stock Option (Right to Buy)
26.615
2018-03-23
4
M
0
5833
0
D
2018-05-08
Common Stock
5833
35001
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
Sale prices reported for the transactions reported here range from $74.63 to $75.41. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Options vest quarterly over a period of one year from date of grant.
/s/ Marissa Song by Power of Attorney for John F. Cogan
2018-03-26